ISRCTN15977623
Active, not recruiting
未知
Intermediate type 2 diabetes trial
Bioepic Ltd0 sites72 target enrollmentJune 27, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bioepic Ltd
- Enrollment
- 72
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 2 diabetes
Exclusion Criteria
- •1\. Body mass index \< 18\.5 kg/m2
- •2\. Pregnancy or lactating
- •3\. Participation in any clinical study during the previous 2 months
- •4\. Any other condition that in the opinion of the investigator would interfere with the evaluation of the study results or constitute a health risk for the participant
- •5\. Any medication that in the opinion of the investigator would interfere with the evaluation of the study results
- •6\. Recreational or illicit drug intake
- •7\. Individuals who fail to utilise the Smartphone App appropriately
- •8\. Aversion to the sight of blood
- •9\. Severe coronary heart disease
- •10\. Participants with known uncontrolled hypertension (i.e. \>160mmHg systolic or \>95 mmHg diastolic)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Early Diabetes Intervention TrialImpaired glucose toleranceNutritional, Metabolic, EndocrineDiabetesISRCTN96631607Bayer plc and Merck-Lipha (UK)631
Recruiting
Not Applicable
Phase II, randomized, double-blind clinical trial for efficacy of Granulocyte-colony stimulating factor(G-CSF) and autologous cord blood infusion in children with cerebral palsyKCT0002512Hanyang University Seoul Hospital98
Completed
Not Applicable
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitusJPRN-UMIN000011287General incorporated Tokyo Physicians Association.100
Not yet recruiting
Phase 2
Pilot Clinical Trial for Treatment of Diabetic Foot Ulcers with Dietary Nano-formulated Phytochemicalsdiabetic foot ulcersMetabolic and Endocrine - DiabetesACTRN12610000565044CamMedica, Ltd.35
Completed
Phase 4
DIAbetes-PREvention Trialpre-diabeticiHeart problemspre-diabetics10011082NL-OMON38088Isala Klinieken78